Ishihara, A., Hatakeyama, S., Suzuki, J., Amano, Y., Sasahara, T., Toshima, M., & Morisawa, Y. (2019). Histological evidence for the cardiac safety of high-dose pegylated liposomal doxorubicin in a patient with HIV-associated Kaposi sarcoma: A case report and literature review. BMC Infect Dis.
Citação norma ChicagoIshihara, Ayaka, Shuji Hatakeyama, Jun Suzuki, Yusuke Amano, Teppei Sasahara, Masaki Toshima, and Yuji Morisawa. "Histological Evidence for the Cardiac Safety of High-dose Pegylated Liposomal Doxorubicin in a Patient With HIV-associated Kaposi Sarcoma: A Case Report and Literature Review." BMC Infect Dis 2019.
ציטוט MLAIshihara, Ayaka, et al. "Histological Evidence for the Cardiac Safety of High-dose Pegylated Liposomal Doxorubicin in a Patient With HIV-associated Kaposi Sarcoma: A Case Report and Literature Review." BMC Infect Dis 2019.